Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity.

Hoeltzenbein M, Stieler K, Panse M, Wacker E, Schaefer C.

PLoS One. 2013 Jun 19;8(6):e66637. doi: 10.1371/journal.pone.0066637. Print 2013.

2.

Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services.

Hoeltzenbein M, Elefant E, Vial T, Finkel-Pekarsky V, Stephens S, Clementi M, Allignol A, Weber-Schoendorfer C, Schaefer C.

Am J Med Genet A. 2012 Mar;158A(3):588-96. doi: 10.1002/ajmg.a.35223. Epub 2012 Feb 8.

PMID:
22319001
3.

Potential teratogenic effects of allopurinol: a case report.

Kozenko M, Grynspan D, Oluyomi-Obi T, Sitar D, Elliott AM, Chodirker BN.

Am J Med Genet A. 2011 Sep;155A(9):2247-52. doi: 10.1002/ajmg.a.34139. Epub 2011 Aug 3.

PMID:
21815259
4.

In utero exposure to mycophenolate mofetil: a characteristic phenotype?

Perez-Aytes A, Ledo A, Boso V, Sáenz P, Roma E, Poveda JL, Vento M.

Am J Med Genet A. 2008 Jan 1;146A(1):1-7.

PMID:
18074358
5.

Retinoic acid embryopathy.

Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW Jr, Lott IT, et al.

N Engl J Med. 1985 Oct 3;313(14):837-41.

PMID:
3162101
6.

An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.

Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y.

J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S13-8. doi: 10.1097/RHU.0b013e31821d36cc.

PMID:
21654265
7.

Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol.

Tamura K, Kawai Y, Kiguchi T, Okamoto M, Kaneko M, Maemondo M, Gemba K, Fujimaki K, Kirito K, Goto T, Fujisaki T, Takeda K, Nakajima A, Ueda T.

Int J Clin Oncol. 2016 Oct;21(5):996-1003. Epub 2016 Mar 26.

PMID:
27017611
8.

Pregnancy outcomes following exposure to abatacept during pregnancy.

Kumar M, Ray L, Vemuri S, Simon TA.

Semin Arthritis Rheum. 2015 Dec;45(3):351-6. doi: 10.1016/j.semarthrit.2015.06.016. Epub 2015 Jun 26.

9.

Major congenital anomalies in children born after frozen embryo transfer: a cohort study 1995-2006.

Pelkonen S, Hartikainen AL, Ritvanen A, Koivunen R, Martikainen H, Gissler M, Tiitinen A.

Hum Reprod. 2014 Jul;29(7):1552-7. Epub 2014 May 7.

PMID:
24812318
10.

Pregnancy outcome post renal transplantation.

Sgro MD, Barozzino T, Mirghani HM, Sermer M, Moscato L, Akoury H, Koren G, Chitayat DA.

Teratology. 2002 Jan;65(1):5-9.

PMID:
11835226
11.

An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.

Huang X, Du H, Gu J, Zhao D, Jiang L, Li X, Zuo X, Liu Y, Li Z, Li X, Zhu P, Li J, Zhang Z, Huang A, Zhang Y, Bao C.

Int J Rheum Dis. 2014 Jul;17(6):679-86. doi: 10.1111/1756-185X.12266. Epub 2014 Jan 28.

PMID:
24467549
12.

Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus.

Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT.

Transplantation. 2006 Dec 27;82(12):1698-702.

PMID:
17198262
14.

An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study.

Kamatani N, Fujimori S, Hada T, Hosoya T, Kohri K, Nakamura T, Ueda T, Yamamoto T, Yamanaka H, Matsuzawa Y.

J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S44-9. doi: 10.1097/RHU.0b013e31821d352f. Erratum in: J Clin Rheumatol. 2014 Sep;20(6):E3. Naoyuki, Kamatani [Kamatani, Naoyuki]; Shin, Fujimori [corrected to Fujimori, Shin]; Toshikazu, Hada [corrected to Hada, Toshikazu]; Tatsuo, Hosoya [corrected to Hosoya, Tatsuo]; Kenjiro, Kohri [corrected to Kohri, Kenjiro]; Toshitaka, Nakamura [corrected to Nakamura, Toshitaka]; Takanori, Ueda [corrected to Ueda, Takanori]; Tetsuya, Yamamoto [corrected to Yamamoto, Tetsuya]; Hisashi, Yamanaka [corrected to Yamanaka, Hisashi]; Yuji, Matsuzawa [Matsuzawa, Yuji].

PMID:
21654269
15.

Successful Pregnancies with Thiopurine-Allopurinol Co-Therapy for Inflammatory Bowel Disease.

Sheikh M, Nelson-Piercy C, Duley J, Florin T, Ansari A.

J Crohns Colitis. 2015 Aug;9(8):680-4. doi: 10.1093/ecco-jcc/jjv072. Epub 2015 May 4.

PMID:
25939351
16.
17.

Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes.

Coppola D, Russo LJ, Kwarta RF Jr, Varughese R, Schmider J.

Drug Saf. 2007;30(3):247-64. Review.

PMID:
17343431
18.
19.

Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.

Ernst ME, Fravel MA.

Clin Ther. 2009 Nov;31(11):2503-18. doi: 10.1016/j.clinthera.2009.11.033. Review.

PMID:
20109996
20.

Valproic acid monotherapy in pregnancy and major congenital malformations.

Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, de Jong-van den Berg LT; EUROCAT Antiepileptic Study Working Group.

N Engl J Med. 2010 Jun 10;362(23):2185-93. doi: 10.1056/NEJMoa0907328. Review.

Supplemental Content

Support Center